Oragenics Inc OGEN:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 05/03/24 EDT
1.07quote price arrow up+0.02 (+1.90%)
Volume
15,512
52 week range
1.00 - 7.74
Loading...
  • Open1.06
  • Day High1.07
  • Day Low1.03
  • Prev Close1.05
  • 52 Week High7.74
  • 52 Week High Date01/03/24
  • 52 Week Low1.00
  • 52 Week Low Date04/29/24

Key Stats

  • Market Cap4.794M
  • Shares Out4.48M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.36
  • YTD % Change-80.98

KEY STATS

  • Open1.06
  • Day High1.07
  • Day Low1.03
  • Prev Close1.05
  • 52 Week High7.74
  • 52 Week High Date01/03/24
  • 52 Week Low1.00
  • 52 Week Low Date04/29/24
  • Market Cap4.794M
  • Shares Out4.48M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.36
  • YTD % Change-80.98

RATIOS/PROFITABILITY

  • EPS (TTM)-8.69
  • P/E (TTM)-0.12
  • Fwd P/E (NTM)-0.09
  • EBITDA (TTM)-20.878M
  • ROE (TTM)-317.98%
  • Revenue (TTM)37,650.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-54,862.55%
  • Debt To Equity (MRQ)9.87%

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Oragenics Inc

 

Content From Our Affiliates

Profile

MORE
Oragenics, Inc. is a development-stage company. It is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. It is focused on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (mTBI or Concussion), and for treating Niemann Pick Disease Type C (NPC), and proprietary powder formulation and an...
Charles Pope
Interim Executive Chairman of the Board
Michael Redmond
President, Interim Principal Executive Officer
Janet Huffman
Chief Financial Officer, Treasurer, Secretary
Address
1990 MAIN STREET, SUITE 750
Sarasota, FL
34236
United States

Top Peers

SYMBOLLASTCHG%CHG
NEXI
Neximmune Inc
3.32+0.20+6.41%
ARTL
Artelo Biosciences Inc
1.35-0.03-2.17%
BPTH
Bio Path Holdings Inc
2.61-0.05-1.88%
PALI
Palisade Bio Inc
7.74+0.45+6.17%
ARTH